NEW YORK, Nov. 25, 2014 /PRNewswire/ -- The points of strongest demand in the global physician office laboratory (POL) market have converged around testing related to lifestyle diseases, according to Kalorama Information. Six of the ten fastest growing tests in the POL market over the next five years are related to diseases such as diabetes, heart disease, thrombosis, and colon cancer. The growth of such POL markets (projected each at over 5% annually) is a result not only of the increasing utilization of such tests in U.S. preventative care, but also their adoption in near-patient testing in the developing world. Physician office laboratory testing, completed during or in conjunction to a primary care visit, has been adopted worldwide to improve routine care with diagnostic technologies able to be leveraged outside of a traditional laboratory setting.
According to Kalorama Information's report Physician Office Laboratory Markets, 3rd. Ed., microalbumin, c-reactive protein (CRP), glycosylated hemoglobin (HbA1c), D-dimer, cardiac markers and fecal occult blood (FOB) tests will see above-average POL market growth to reach nearly 16% of the total POL market in 2019. All six tests and test families can be performed outside of a laboratory with rapid results. Fecal occult blood and HbA1c tests are two of the twelve most-performed POL tests in the U.S. market; three of the tests (FOB, HbA1c, cardiac markers) can be performed without CLIA lab certification. The surprising aspect of market success for these POL tests, however, is their fast-growing application in developing markets.
"POL or physician office testing isn't typically associated with the developing world; outside of the United States, Europe and Japan there's only 5% of the global market remaining," explained Emil Salazar, report analyst for Kalorama Information. "But as growth has cooled in more established POL markets in the past few years, we are seeing rising placements of near-patient and POC test devices at clinics in India and China."
A confluence of factors in India has particularly assisted the development of the POL market. Economic development and rising incomes have increased the prevalence of diabetes and cardiovascular disease. Amid uneven and at times problematic healthcare modernization in India, patients there have turned to private clinics and primary healthcare centers modeled after Western practices. In such institutions, POL testing is increasingly a fixture valuable in reassuring patients through timely, in-house performed test results. A fleet of tests are expected to see deployment in rest of world (ROW) POL markets including CRP, glucose, HbA1c, basic lipid profiles, and cardiac markers CK and BNP.
The expansive market selection of POL tests is analyzed through a series of market segments in Kalorama Information's report, as are the varying prospects of national and regional POL markets. Physician Office Laboratory Markets, 3rd Ed. can be found at: http://www.kaloramainformation.com/redirect.asp?progid=86861&productid=8339073.
About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
SOURCE Kalorama Information